NOVANT HEALTH MINT HILL MEDICAL CTR
1. Target Overview & Investment Thesis
NOVANT HEALTH MINT HILL MEDICAL CTR is a 36-bed suburban community hospital in nan, NC with $107.8M in net patient revenue and a 9.7% operating margin. The hospital serves a payer mix of 24.9% Medicare, 3.4% Medicaid, and 71.7% commercial.
Thesis: Turnaround. Our ML models identify $7.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.7% to 17.0% (+736bps).
| Net Revenue HCRIS | $107.8M |
| Current EBITDA COMPUTED | $10.4M |
| Operating Margin COMPUTED | 9.7% |
| Occupancy HCRIS | 82.7% |
| Revenue / Bed COMPUTED | $3.0M |
| Net-to-Gross HCRIS | 27.9% |
| Distress Probability ML | 37.4% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 9.7% places it above the state median. Among 43 size-comparable peers (18-72 beds), the median margin is -4.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (18-72), prioritizing same-state peers. 43 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NOVANT HEALTH MINT HILL MEDICA (Target) | NC | 36 | $107.8M | 9.7% |
| BRUNSWICK COMMUNITY HOSPITAL | NC | 65 | $143.2M | 12.9% |
| LEXINGTON MEMORIAL HOSPITAL I | NC | 70 | $138.3M | 6.9% |
| DAVIE MEDICAL CENTER | NC | 42 | $108.5M | 27.5% |
| THE OUTER BANKS HOSPITAL | NC | 21 | $93.7M | 26.2% |
| VIDANT ROANOKE CHOWAN HOSPITAL | NC | 70 | $88.5M | -12.2% |
| MEDICAL PARK HOSPITAL | NC | 22 | $82.6M | 15.8% |
| GRANVILLE MEDICAL CENTER | NC | 42 | $81.5M | -5.4% |
| NORTH CAROLINA SPECIALTY HOSPI | NC | 18 | $71.6M | 11.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $69K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $10.4M |
| + RCM Uplift | +$7.9M |
| Pro Forma EBITDA | $18.3M |
| Current Margin | 9.7% |
| Pro Forma Margin | 17.0% |
| WC Released (1x) | $4.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $16.0M | $148.0M | 9.24x | 56.0% |
| Base (11x exit) | 10.0x | 11.0x | $16.0M | $168.0M | 10.49x | 60.0% |
| Bull Case | 9.0x | 11.0x | $14.4M | $199.3M | 13.83x | 69.1% |
| Bull (12x exit) | 9.0x | 12.0x | $14.4M | $221.7M | 15.39x | 72.8% |
| Bear Case | 11.0x | 10.0x | $17.6M | $103.1M | 5.85x | 42.4% |
| Bear (11x exit) | 11.0x | 11.0x | $17.6M | $119.1M | 6.76x | 46.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 43 hospitals with 18-72 beds
- Same-state prioritization (n=44)
- Comp margins: P25=-19.3% / P50=-4.3% / P75=7.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.